Aktienanalyse zu Joint Corp (JYNT)JYNTJoint Corp

The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations. It operates in the Healthcare sector (PATENT OWNERS & LESSORS industry).

Joint Corp (JYNT) is currently priced at $8.43, which is below the analyst price target of $12, indicating potential upside. However, the stock has a relatively high forward P/E of 19.88, suggesting it may be overvalued at this price point. The recent insider buying activity increased by 24955.71%, signaling strong confidence from insiders, but the stock's RSI of 49.52 indicates a neutral momentum. The main risk is the recent earnings report where EPS was -0.01, missing estimates by 109.09%, which could impact investor sentiment negatively.

3 analysts cover JYNT: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 11.33.